title: Frequency of hospitalization and severe events in 497 spondylarthritis patients treated with anti-TNF drugs: comparisons with 423 RA patients.
authors.forename: Stéphanie
authors.initials: S
authors.lastname: Gérard-Benoist
authors.forename: Christophe
authors.initials: C
authors.lastname: Leux
authors.forename: Benoît
authors.initials: B
authors.lastname: Le Goff
authors.forename: Yves
authors.initials: Y
authors.lastname: Maugars
authors.forename: Jean-Marie
authors.initials: JM
authors.lastname: Berthelot
mesh_terms: D000328:Adult; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D003093:Colitis, Ulcerative / Q000139:chemically induced / Q000453:epidemiology; D003424:Crohn Disease / Q000139:chemically induced / Q000453:epidemiology; D005260:Female; D006760:Hospitalization / Q000706:statistics & numerical data*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012189:Retrospective Studies; D025241:Spondylarthritis / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha